Ideological Capture’ Exposed: AHPRA’s Secret Partnership with Trans in Australia

‘Ideological Capture’ Exposed: AHPRA’s Secret Partnership with Trans Lobby Group ACON Raises Serious Questions About Medical Regulation in Australia

In a revelation that has sent shockwaves through Australia’s medical and faith communities, fresh Freedom of Information (FOI) documents have exposed the extent to which Australia’s peak health regulator, the Australian Health Practitioner Regulation Agency (AHPRA), has aligned itself with radical gender ideology through its close partnership with the powerful trans lobby group ACON.

While AHPRA has aggressively investigated and silenced doctors who dared to question the safety and ethics of gender-transition procedures on minors, the same regulator was quietly developing a three-to-five-year strategy to embed gender ideology into its regulatory framework — all while fighting to keep these plans hidden from public scrutiny.

This is not just a story about bureaucratic overreach. It is a story about ideological capture of one of Australia’s most powerful institutions — one tasked with protecting public safety.

The Damning Evidence

Documents obtained by The Australian reveal that AHPRA’s leadership viewed its relationship with ACON (formerly the AIDS Council of NSW) and Rainbow Health Australia not as a simple diversity initiative, but as a guiding framework for how it should “regulate and fulfil its purpose of ensuring the preservation of public safety.”

An internal February 2024 National Executive agenda paper, marked “In Confidence,” outlined the development of a National Scheme LGBTIQA+ Equity and Inclusion Strategy. This was not limited to internal workplace policies. It explicitly aimed at reforming “people, policies, and regulatory processes” over a 3–5 year period, including “improving access to the National Scheme” and influencing National Board portfolios.

In other words, AHPRA was allowing a partisan advocacy group — one that promotes rapid gender affirmation and medical transition for minors — to help shape how doctors are trained, regulated, and disciplined across Australia.

This occurred at the same time AHPRA was punishing medical professionals who raised legitimate, evidence-based concerns about the Cass Review findings in the UK, the growing evidence of harm from puberty blockers, and the lack of long-term data on the safety of cross-sex hormones and surgeries.

Double Standards and Selective Enforcement

The contrast is stark and deeply troubling:

• Doctors like Dr Andrew Amos (Queensland psychiatrist) and Dr Jillian Spencer (child psychiatrist) have faced investigations, restrictions, or outright bans for voicing concerns about gender medicine.
• Meanwhile, clinicians who aggressively advocate for medical transition — even when criticised by courts — appear to face little to no consequences.
• AHPRA has reportedly registered multiple trans-identified male doctors as “female,” raising serious questions about women’s safety and single-sex spaces in healthcare.

As Rachael Wong, CEO of Women’s Forum Australia, rightly stated:

“AHPRA must urgently cut ties with ACON if it is going to regain its independence and the public’s trust.”

The parents’ group Parents of Adolescents with Gender Distress also highlighted the dangerous double standard:

“Gender clinicians who publicly advocate for these controversial interventions face no restrictions, while practitioners who voice valid critique have been unduly penalised.”

Why This Matters Deeply

This scandal strikes at the heart of medical ethics and public trust. AHPRA’s statutory duty is to protect the public by ensuring that only safe, evidence-based, and ethical medical practice is allowed. When a regulator begins shaping its policies around the agenda of a highly ideological lobby group — especially one that has faced credible criticism for suppressing dissent and promoting experimental treatments on children — it compromises its entire mandate.

The use of disputed statistics (such as the claim that transgender youth aged 14–25 are “15 times more likely to attempt suicide”) without proper context or acknowledgment of conflicting research further reveals a clear ideological bias rather than a commitment to rigorous, evidence-based regulation.

Worse still, AHPRA actively fought to keep these documents secret, claiming that releasing them would discourage “unconventional, controversial, challenging or novel” views — a revealing admission that suggests the regulator sees itself as a protector of certain ideologies rather than a neutral guardian of medical standards.

A Call for Accountability and Reform

This situation demands urgent and transparent action:

1. Immediate severance of all formal partnerships between AHPRA and ACON/Rainbow Health Australia.
2. Independent review of AHPRA’s regulatory decisions regarding gender medicine over the past five years.
3. Full transparency — all internal documents related to the LGBTIQA+ strategy must be released without redactions.
4. Restoration of free speech for doctors to engage in legitimate scientific debate without fear of professional ruin.
5. Return to evidence-based medicine — especially when it comes to the experimental and irreversible medicalisation of children and adolescents.

As Christians, we believe that every human being is made in the image of God and deserves compassion, dignity, and truthful care. True compassion does not mean affirming confusion or rushing vulnerable young people toward life-altering medical interventions with poor long-term evidence. Real love speaks truth, even when it is unpopular.

The Church has a vital role to play — not only in praying for healing and clarity in this area, but in courageously defending the truth that biological sex is a created reality, not a social construct, and that children must be protected from ideological experiments disguised as healthcare.

Final Thought

The exposure of AHPRA’s deep ties with ACON should serve as a wake-up call for all Australians. When regulatory bodies entrusted with public safety become captured by powerful ideological interests, the most vulnerable — especially gender-distressed children and adolescents — suffer the consequences.

AHPRA must choose: Will it serve science, evidence, and the public good — or will it continue to serve ideology?

The credibility of Australia’s entire medical regulatory system now hangs in the balance.